Daniel Alan Kerr, MD

Dr. D. Alan Kerr is a hematologist-oncologist and physician scientist with Tampa General Hospital, where he previously conducted continuity clinic work with a focus on malignant hematology. He specializes in malignant hematology.

Prior to joining Tampa General, Dr. Kerr treated patients in a private community practice at Advanced Cancer Treatment Centers (ACTC) in Brooksville, Fla., after completing a three-year hematology and medical oncology fellowship program with Moffitt Cancer Center/University of South Florida. Before that, he completed an internal medicine residency program at the University of Louisville in Kentucky, where he served as a chief medical resident. In the same department, he followed his passion for teaching future medical professionals as an assistant professor from 2015 to 2016. Dr. Kerr received his medical degree from the University of Louisville School of Medicine and holds a PhD in biochemistry and molecular biology from the University of Louisville.



Dr. Kerr is a site investigator for numerous active clinical trials, and his primary clinical interests is lymphomas. Well-versed in translational research and clinical research protocols, Dr. Kerr is credited with several publications, oral presentations and abstracts on a wide range of oncology topics. He is a diplomate of the American Board of Internal Medicine and a member of the American Society of Clinical Oncology and the American Society of Hematology.



Conditions Treated:


Lymphoma


Leukemia


Myeloma